Immunology sponsored testing program 

Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria


Rare primary immunodeficiencies, severe congenital neutropenia, WHIM Syndrome

X4 Pharmaceuticals, Inc. has partnered with Invitae to offer third-party sponsored genetic testing at no charge for individuals who may carry a genetic mutation known to be associated with severe chronic and/or congenital neutropenia (SCN), including WHIM syndrome.

SCN consists of a heterogeneous group of rare hematological diseases characterized by a selective decrease in circulating neutrophils, impaired maturation or trafficking, and higher risk of recurrent severe infections.